I think mid 2027 or sooner . Trial finishes recruiting end of this year at latest, one year follow up, takes us to end of 2026. Approval mid 2027?
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
2.47%
!
$1.78

Cell Therapy News/Articles, page-19634
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.78 |
Change
-0.045(2.47%) |
Mkt cap ! $2.261B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $9.064M | 5.085M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4254 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 13795 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 19529 | 1.770 |
17 | 41780 | 1.765 |
11 | 23026 | 1.760 |
14 | 92734 | 1.755 |
25 | 161267 | 1.750 |
Price($) | Vol. | No. |
---|---|---|
1.775 | 21763 | 29 |
1.780 | 42223 | 18 |
1.785 | 72918 | 11 |
1.790 | 31982 | 8 |
1.795 | 77508 | 6 |
Last trade - 14.23pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online